Marico
- Market Cap
- ₹1,19,195 Cr
- P/E
- 59.03
Key Fundamentals
LargecapConsumer GoodsFMCGPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 47.00%
- Debt to Equity
- 0.26
- EPS (TTM)
- ₹15.53
- Book Value
- ₹36.42
- Market Cap
- ₹1,19,195 Cr
- P/E (TTM)
- 59.03
- P/B
- 25.17
- ROE
- 42.90%
- Dividend Yield
- 0.44%
- EBITDA
- ₹2,532 Cr
- 52W High
- ₹925.00
- 52W Low
- ₹707.25
- Day Range
- ₹907.55 – ₹918.95
- Volume
- 11,74,167
Peer Comparison
Fast Moving Consumer Goods › Agricultural Food & other Products › Edible Oil
| 916.75 | 59.03 | 1,19,195 | 25.17 | 0.44% | 42.90% | 47.00% | 14,692 | 2,078 | |
| 401.05 | 23.28 | 43,639 | 3.25 | 0.19% | 16.00% | 12.10% | 44,299 | 1,874 | |
| 165.27 | 18.65 | 21,480 | 1.97 | 0.61% | 10.70% | 18.30% | 82,318 | 1,152 | |
| 224.01 | 14.20 | 6,610 | 3.90 | 0.00% | 30.00% | 36.70% | 25,277 | 466 | |
| 1,062.65 | 9.23 | 2,974 | 1.31 | 0.00% | 10.80% | 12.30% | 2,384 | 323 | |
| 724.50 | 108.13 | 1,603 | 12.23 | 0.13% | 33.70% | 19.80% | 597 | 15 | |
| 203.00 | 14.24 | 507 | 1.32 | 0.00% | 8.86% | 13.60% | 1,945 | 36 | |
| Median 7 companies | 401.05 | 18.65 | 6,610 | 3.25 | 0.13% | 16.00% | 18.30% | 14,692 | 466 |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 78
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 26
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 70
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 88
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 76
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 52
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company has a good return on equity (ROE) track record: 3 Years ROE 41.0%
- Company has been maintaining a healthy dividend payout of 65.1%
Weaknesses
2- Stock is trading at 25.1 times its book value
- The company has delivered a poor sales growth of 11.1% over past five years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 3 | 3 | 13 |
| Oscillators | Neutral | 3 | 3 | 3 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Neutral
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 70.85
- Bearish
- MACD (12,26,9)
- 31.04
- Bullish
- SMA (50)
- 817.65
- Bullish
- SMA (200)
- 808.62
- Bullish
As of
Analyst Rating
33 of 38 analysts rate Buy, 5 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +8.51% |
|---|---|
| 5Y | +11.08% |
| 3Y | +11.71% |
| 1Y | +25.67% |
| TTM | +20.48% |
Net profit
| 10Y | +9.63% |
|---|---|
| 5Y | +8.62% |
| 3Y | +11.10% |
| 1Y | +9.35% |
| TTM | +22.52% |
Operating cash flow
| 10Y | +9.80% |
|---|---|
| 5Y | +0.76% |
| 3Y | +13.67% |
| 1Y | +52.90% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −0.37 pp |
|---|---|
| 5Y | −2.64 pp |
| 3Y | −1.44 pp |
| 1Y | −2.65 pp |
| TTM | −0.11 pp |
Revenue by year
| Mar 2017 | ₹5,918 Cr |
|---|---|
| Mar 2018 | ₹6,322 Cr |
| Mar 2019 | ₹7,334 Cr |
| Mar 2020 | ₹7,315 Cr |
| Mar 2021 | ₹8,048 Cr |
| Mar 2022 | ₹9,512 Cr |
| Mar 2023 | ₹9,764 Cr |
| Mar 2024 | ₹9,653 Cr |
| Mar 2025 | ₹10,831 Cr |
| Mar 2026 | ₹13,611 Cr |
Net profit by year
| Mar 2017 | ₹811 Cr |
|---|---|
| Mar 2018 | ₹827 Cr |
| Mar 2019 | ₹1,131 Cr |
| Mar 2020 | ₹1,043 Cr |
| Mar 2021 | ₹1,199 Cr |
| Mar 2022 | ₹1,255 Cr |
| Mar 2023 | ₹1,322 Cr |
| Mar 2024 | ₹1,502 Cr |
| Mar 2025 | ₹1,658 Cr |
| Mar 2026 | ₹1,813 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Marico Ltd trades at ₹925 as of 2026-11-11 with a market cap of ₹1,17,862 crore and a PE (TTM) of 59.56. The company combines a strong return on equity of 40.34% with minimal leverage (debt-to-equity of 0.13), while TTM sales and profit growth have accelerated to 20% and 21% respectively. However, the stock trades at 25.4 times book value and sits at its 52-week high, raising questions about how much of the recent acceleration is already priced in.
- Exceptional return on equity at 40.34% as of 2026-11-11, supported by a 3-year average ROE of 41% and a 10-year average of 38%, indicating consistently superior capital efficiency
- TTM profit growth of 21% marks a meaningful acceleration compared to the 5-year compounded profit growth of 9% and the 10-year CAGR of 10%
- TTM sales growth of 20% is nearly double the 5-year compounded sales growth of 11%, suggesting a broad-based pick-up in demand or pricing power
- Near-zero financial risk with a debt-to-equity ratio of just 0.13, giving the company significant balance sheet flexibility for acquisitions or capacity expansion
- Healthy dividend payout ratio of 65.1% demonstrates shareholder-friendly capital allocation alongside a dividend yield of 0.44%
- Stock has delivered a 1-year return CAGR of 25% and a 3-year CAGR of 20%, outpacing the 10-year CAGR of 14%, reflecting improving investor confidence
- ROCE of 39% complements the high ROE, confirming that returns are driven by operational efficiency rather than financial leverage alone
- PE (TTM) of 59.56 is well above typical FMCG sector averages, demanding sustained high earnings growth to justify the premium
- Five-year compounded sales growth of only 11% suggests the recent TTM acceleration to 20% may not be sustainable over a longer horizon
- At ₹925 the stock sits exactly at its 52-week high (range ₹706.75–₹925), meaning there is no price cushion from recent highs
- Dividend yield of just 0.44% provides minimal income support relative to prevailing risk-free rates in India
- Five-year stock CAGR of only 10% versus a 10-year CAGR of 14% indicates a period of underperformance before the recent rally, hinting at cyclical valuation swings
- Five-year compounded profit growth of 9% trails the 3-year rate of 11% and the TTM rate of 21%, raising the question of whether recent margin expansion is structural or transient
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Marico delivered a standout Q2 FY27 with 31% PAT growth, record gross margins, and volume-led domestic expansion headlined by Parachute's 22-quarter-high growth. The foods portfolio at ₹1,500 crore ARR and raised FY27/Vision 2030 targets signal strong execution. Key risks are copra price normalization threatening the margin-funded ad blitz, renewed input cost inflation from geopolitics, and the deliberate Saffola oils volume reset. The trend is clearly improving, but sustainability hinges on whether market share gains prove sticky when the commodity tailwind fades.
- Input cost pressure flagged Nov 02
MD Saugata Gupta flagged renewed input cost pressures from geopolitical tensions in West Asia and weather-related concerns, with consumer inflation rising led by food, edible oil, and fuel.
- Copra reversal risk to margins Nov 02
Copra prices are ~35% below peak, funding the 600bps gross margin expansion and 44% A&P surge. A normalization in copra prices would pressure the 18.2% EBITDA margin and force tough trade-offs on ad spend.
- Saffola oils volume decline Nov 02
Saffola edible oils saw a high-single-digit volume decline in Q2 FY27 as Marico deliberately sacrificed low-margin volumes; revenue still grew 6% on premiumization but the reset will take 2-3 quarters.
- Q2 PAT surges 31% YoY Nov 02
Consolidated net profit rose 31% YoY to ₹550 crore in Q2 FY27, the highest PAT growth in 51 quarters. EBITDA grew 27% to ₹709 crore with margin expanding 200bps to 18.2%.
- Parachute volume growth 22Q high Nov 02
Parachute Rigids posted 13% volume growth, its strongest in 22 quarters, gaining 570+ bps in market share to reach 60% volume share in coconut oil.
- Foods portfolio crosses ₹1,500cr ARR Nov 02
The Foods portfolio grew 45% YoY and crossed ₹1,500 crore annualized run rate. Foods profit is now ~5x FY26 levels with a 10x target by FY30.
- Rohit Jawa joins as director Nov 02
Marico appointed Rohit Jawa, former HUL CEO, as Additional Independent Director for a five-year term starting January 1, 2027, subject to shareholder approval.
- Emissions intensity down 89.3% Oct 22
Marico reported an 89.3% reduction in Scope 1 and 2 GHG emissions intensity versus FY13, with renewable energy covering 77.3% of operational consumption.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,476 | 2,422 | 2,278 | 2,643 | 2,664 | 2,794 | 2,730 | 3,221 | 3,450 | 3,537 | 3,301 | 3,957 | 3,897 |
| Expenses | 1,979 | 1,909 | 1,836 | 2,017 | 2,142 | 2,261 | 2,272 | 2,566 | 2,890 | 2,945 | 2,780 | 3,138 | 3,188 |
| Operating Profit | 497 | 513 | 442 | 626 | 522 | 533 | 458 | 655 | 560 | 592 | 521 | 819 | 709 |
| OPM % | 20% | 21% | 19% | 24% | 20% | 19% | 17% | 20% | 16% | 17% | 16% | 21% | 18% |
| Other Income | 38 | 43 | 15 | 37 | 82 | 42 | 47 | 56 | 49 | 39 | 60 | 48 | 53 |
| Interest | 20 | 19 | 17 | 17 | 11 | 13 | 12 | 10 | 12 | 14 | 17 | 21 | 24 |
| Depreciation | 39 | 42 | 41 | 41 | 41 | 44 | 52 | 45 | 47 | 50 | 60 | 56 | 64 |
| PBT | 476 | 495 | 399 | 605 | 552 | 518 | 441 | 656 | 550 | 567 | 504 | 790 | 674 |
| Tax % | 24% | 22% | 20% | 22% | 22% | 22% | 22% | 22% | 21% | 19% | 19% | 17% | 17% |
| Net Profit | 360 | 386 | 320 | 474 | 433 | 406 | 345 | 513 | 432 | 460 | 408 | 652 | 558 |
| EPS (₹) | 2.73 | 2.96 | 2.46 | 3.58 | 3.27 | 3.08 | 2.65 | 3.89 | 3.24 | 3.44 | 3.01 | 4.85 | 4.23 |
| YoY Sales growth | −1 | −2 | 2 | 7 | 8 | 15 | 20 | 22 | 30 | 27 | 21 | 23 | 13 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,733 | 6,017 | 5,918 | 6,322 | 7,334 | 7,315 | 8,048 | 9,512 | 9,764 | 9,653 | 10,831 | 13,611 | 14,692 |
| Expenses | 4,863 | 4,966 | 4,759 | 5,185 | 6,009 | 5,846 | 6,459 | 7,831 | 7,954 | 7,627 | 8,692 | 11,283 | 12,051 |
| Operating Profit | 870 | 1,051 | 1,159 | 1,137 | 1,325 | 1,469 | 1,589 | 1,681 | 1,810 | 2,026 | 2,139 | 2,328 | 2,641 |
| OPM % | 15% | 17% | 20% | 18% | 18% | 20% | 20% | 18% | 19% | 21% | 20% | 17% | 18% |
| Other Income | 59 | 93 | 96 | 85 | 103 | 95 | 107 | 98 | 144 | 142 | 208 | 204 | 200 |
| Interest | 23 | 21 | 17 | 16 | 40 | 50 | 34 | 39 | 56 | 73 | 53 | 53 | 76 |
| Depreciation | 84 | 95 | 90 | 89 | 131 | 140 | 139 | 139 | 155 | 158 | 178 | 202 | 230 |
| PBT | 822 | 1,029 | 1,149 | 1,117 | 1,257 | 1,374 | 1,523 | 1,601 | 1,743 | 1,937 | 2,116 | 2,277 | 2,535 |
| Tax % | 29% | 30% | 29% | 26% | 10% | 24% | 21% | 22% | 24% | 22% | 22% | 20% | — |
| Net Profit | 585 | 723 | 811 | 827 | 1,131 | 1,043 | 1,199 | 1,255 | 1,322 | 1,502 | 1,658 | 1,813 | 2,078 |
| EPS (₹) | 4.45 | 5.51 | 6.19 | 6.31 | 8.63 | 7.91 | 9.08 | 9.48 | 10.07 | 11.44 | 12.57 | 13.57 | 15.53 |
| Div. Payout % | 28% | 77% | 57% | 67% | 55% | 85% | 83% | 97% | 45% | 83% | 83% | 30% | — |
| Sales growth | 22 | 5 | −2 | 7 | 16 | 0 | 10 | 18 | 3 | −1 | 12 | 26 | 20 |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 64 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 130 | 130 |
| Reserves | 1,760 | 1,888 | 2,197 | 2,414 | 2,846 | 2,894 | 3,111 | 3,219 | 3,670 | 3,703 | 3,846 | 4,080 | 4,605 |
| Borrowings | 428 | 331 | 239 | 312 | 352 | 338 | 511 | 479 | 608 | 528 | 554 | 557 | 1,238 |
| Other Liabilities | 873 | 1,010 | 1,059 | 1,217 | 1,569 | 1,603 | 1,675 | 1,850 | 2,393 | 2,993 | 3,746 | 5,183 | 6,405 |
| Total Liabilities | 3,125 | 3,358 | 3,623 | 4,072 | 4,896 | 4,964 | 5,426 | 5,677 | 6,800 | 7,353 | 8,275 | 9,950 | 12,378 |
| Fixed Assets | 1,076 | 1,050 | 1,085 | 1,110 | 1,300 | 1,396 | 1,612 | 1,760 | 2,246 | 2,724 | 2,758 | 3,633 | 3,960 |
| CWIP | 3 | 37 | 11 | 27 | 45 | 58 | 24 | 39 | 67 | 44 | 40 | 85 | 144 |
| Investments | 284 | 544 | 608 | 543 | 450 | 733 | 854 | 828 | 1,096 | 602 | 1,590 | 2,083 | 2,634 |
| Other Assets | 1,763 | 1,727 | 1,919 | 2,392 | 3,101 | 2,777 | 2,936 | 3,050 | 3,391 | 3,983 | 3,887 | 4,149 | 5,640 |
| Total Assets | 3,125 | 3,358 | 3,623 | 4,072 | 4,896 | 4,964 | 5,426 | 5,677 | 6,800 | 7,353 | 8,275 | 9,950 | 12,378 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 665 | 818 | 649 | 516 | 1,062 | 1,214 | 2,007 | 1,016 | 1,419 | 1,387 | 1,363 | 2,084 |
| Investing | −186 | −203 | −125 | 59 | −367 | −22 | −933 | 441 | −928 | 176 | −621 | −722 |
| Financing | −625 | −601 | −574 | −567 | −698 | −1,147 | −1,058 | −1,290 | −560 | −1,542 | −649 | −1,279 |
| Net Cash Flow | −147 | 14 | −51 | 8 | −3 | 45 | 16 | 167 | −69 | 21 | 93 | 83 |
| Free Cash Flow | 607 | 731 | 567 | 388 | 919 | 1,034 | 1,870 | 884 | 1,237 | 1,234 | 1,241 | 1,772 |
| CFO/EBITDA | 101 | 101 | 82 | 71 | 104 | 102 | 144 | 81 | 99 | 87 | 86 | 114 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 15 | 15 | 20 | 26 | 27 | 18 | 25 | 38 | 40 | 43 | 35 |
| Inventory Days | 139 | 110 | 193 | 190 | 147 | 157 | 108 | 106 | 94 | 116 | 93 | 85 |
| Days Payable | 79 | 80 | 107 | 103 | 98 | 108 | 109 | 101 | 112 | 137 | 103 | 108 |
| Cash Conversion Cycle | 71 | 46 | 101 | 106 | 74 | 76 | 17 | 30 | 20 | 19 | 33 | 12 |
| Working Capital Days | 18 | 0 | 23 | 37 | 27 | 24 | −11 | 5 | 2 | 14 | 16 | −18 |
| ROCE % | 38% | 44% | 45% | 42% | 42% | 43% | 43% | 43% | 42% | 43% | 45% | 47% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Marico insights
64 extracted metrics across FY07–FY27.
Documents
- Q2 FY27 concall · Nov 2026Transcript PPT Recording
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Q4 FY26 concall · May 2026Transcript PPT
- Concall · Feb 2026Transcript PPT
- Q3 FY26 concall · Jan 2026Transcript PPT Recording
- 2 Sep 2026
- 7 Jul 2025
- 25 Apr 2024
- 31 Mar 2023
- 12 Jan 2022
- General announcements 13 Nov 2026
Frequently Asked Questions about Marico
What does Marico Ltd do?
Where is Marico Ltd (MARICO) listed?
Which sector does Marico Ltd belong to?
What is the market capitalisation of Marico Ltd?
What is the PE ratio of Marico Ltd?
What is the 52-week high and low of Marico Ltd?
Does Marico Ltd pay dividends?
What is the Return on Equity (ROE) of Marico Ltd?
Company Information
Marico Limited is one of India's leading consumer goods companies, operating across beauty, personal care, wellness and foods in India and select international markets. Portfolio includes Parachute, Saffola, Hair & Care, Nihar, Livon, Set Wet, Beardo, Just Herbs, True Elements, Plix, Cosmix and 4700BC; products reach 1 out of 3 Indians.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/MARICO.md for Marico Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.